GeminIQ Website Logo

Viewing ADAD free

Start free trial

Subscribe for full history, 50+ metrics, screener, watchlist...

Huaizhong Health Group, Inc.

ADAD

Companies in Services-Prepackaged Software

MSFTORCLPLTRSHOPCRMCRWD

Huaizhong Health Group, Inc. (ADAD) — SEC Financial Statements & Analysis

Huaizhong Health Group, Inc. (ADAD) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
2020-04-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets New
Cash And Cash Equivalents At Carrying Value
----0000-000
Cash
0000-0-0000-
Assets Current
Assets Current
0000000000-0
Prepaid Expense Current
0000-0-----0
Assets
000000000000
Liabilities And Stockhold…
Liabilities And Stockhold…
Accrued Liabilities And Other Liabilities
----------00
Liabilities Current
Convertible Long Term Notes Payable
----------00
Liabilities Current
0000000000--
Accounts Payable And Accrued Liabilities Current
----0-0000--
Accounts Payable Current
0000-0---0--
Due To Related Parties Current
0000000000--
Liabilities
000000000000
Convertible Notes Payable
---------0--
Stockholders Equity
Common Stock Shares Autho…
Class Of Warrant Or Right Outstanding
----0-------
Common Stock Value
0000-0000000
Additional Paid In Capital
000000000000
Retained Earnings Accumulated Deficit
-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity
-0-0-0-0-0-0-0-0-0-0-0-0
Liabilities And Stockholders Equity
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
750750750750750750750750750750750750
Common Stock Shares Issued
221221221221221221221221221221221207
Shares Outstanding
221221221221221221221221221221221207

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20230.00%0.00%0.00%---------
2022131.54%-32.21%-32.21%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-89.00%-89.00%
2021-36.50%-36.50%-36.50%0.00%0.00%0.00%0.00%0.00%0.00%2.34%-0.78%169.53%
2020----20.31%-20.31%-20.31%0.00%-47.04%-45.08%187.50%5.83%5.83%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
2020-04-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.01
0.02
0.09
0.04
-
-
-
-
-
-
-
-
Quick Ratio
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
Working Capital
-90.02K
-79.47K
-72.13K
-66.18K
-
-
-
-
-
-
-
-
Leverage & Debt
Debt to Equity
-1.01
-1.02
-1.09
-1.04
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
-
-
Debt Ratio
181.04
64.58
11.69
25.06
-
-
-
-
-
-
-
-
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
399.79
Per Share Metrics
Free Cash Flow Per Share TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
0.00
0.00
0.00
0.00
-0.00
0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-
-
-
-
-
-
-
-
-45.93%
Net Profit Margin TTM
-
-
-
-
-
-
-
-
-
-
-
-46.02%
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-
-
-
-
-100.00%
-100.00%
-100.00%
-100.00%
1,358.79%
Net Income Growth (1Y)
2.48%
-5.38%
-34.48%
-51.88%
-30.86%
-15.49%
-26.60%
-65.12%
-67.82%
-71.07%
-41.83%
1,887.15%
EPS Growth (1Y)
2.48%
-5.38%
-34.48%
-51.88%
-30.86%
-15.49%
-26.60%
-67.25%
-69.78%
-99.93%
-73.07%
879.86%
Calculated Values
Free Cash Flow TTM
-20.90K
-30.57K
-31.79K
-31.79K
-41.47K
-31.79K
0.00
0.00
0.00
0.00
-14.17K
0.00
Net Debt
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.70K
20.96K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial
No insider data available.

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

Research Faster.
Invest Smarter.

Start 7-day free trial

Huaizhong Health Group, Inc. (ADAD) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.